Cabel asked (paraphrasing): once DBL happens....Who has access to the data? Who does the number crunching? How long to analyze? Is it a manual or automated process (or combination) for analysis.
All great questions that I do not have the answers to. Tick tock.
Carman asked "Bear, how could they even consider RVX if no one now knows what the top line data will be; or do they consider even not the best of trial results?"
Top-line data availability is not required for a trial to be considered and given a late breaking clinical trial presentation. Perfect example.....Amarin's REDUCE-IT trial.
BearDownAZ
